Growth Factors for Bone, Dental, Cartilage & Tendon Repair
Competitor Analysis
Product description
The present Competitive Intelligence Report about growth factors for bone, dental, cartilage and tendon repair provides a competitor evaluation in the field of molecules such as proteins, peptides, antibodies... |
Peroxisome Proliferator-Activated Receptor (PPAR) Agonists
Competitor Analysis
The present Competitive Intelligence Report about PPAR Agonists provides a competitor evaluation in the field of peroxisome proliferator-activated receptor targeting small molecule agonists for treatment of type 2 diabetes and/or... |
Antithrombotics
Competitor Analysis
Product description
The Competitive Intelligence Report Antithrombotics as of August 2008 provides a competitor analysis in the development pipeline of novel anticoagulants and antiplatelet agents for prophylaxis and treatment of venous... |
Drug Targets for Breast Cancer
In Europe consolidation has been the order of the day throughout 2006, with many mid-sized companies being acquired - Bayer acquiring Schering AG, Schwarz bought by UCB to name a... |
Competitor Analysis: Emerging Diabetes Drugs
The present Competitive Intelligence Report about Emerging Diabetes Drugs provides a competitor evaluation in the field of novel molecules against a series of novel targets being developed for treatment of... |
Type 2 Diabetes
Pipeline Assessment and Market Forecasts to 2017
GlobalData, the industry analysis specialist, has released its new report, "Type 2 Diabetes - Pipeline Assessemnt and Market Forecasts to 2017". The report is an essential source of information and... |
CXCR and CXCL Agonists and Antagonists
Competitor Analysis
The present Competitive Intelligence Report about CXCR agonists and CXCR/CXCL antagonists provides a competitor evaluation in the field of chemokine receptor CXCR or its ligands CXCL targeting molecules for tissue... |
NGF Agonists and Antagonists
Competitor Analysis
The present Competitive Intelligence Report about Nerve Growth Factor (NGF) Agonists & Antagonists provides a competitor evaluation in the field of investigational antibodies, small molecules and gene therapeutic approaches for... |
Chinese Markets for Asthma Treatment Drugs
China's demand for Asthma Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This... |
Competitor Analysis: Targeted Therapy of Diabetes
The present Competitive Intelligence Report about Targeted Therapy of Diabetes provides a competitor evaluation in the field of novel molecules being developed for treatment of type 1 and 2 diabetes... |
Stakeholder Opinions: Endometriosis
Scientific Clarity Will Unlock Market Potential
Introduction
Endometriosis is a painful, menstrual-related disorder that is thought to affect approximately 10% of the female population of reproductive age. Despite this large patient potential, growth of the endometriosis market... |
Alzheimer's and Parkinson's Disease
This report analyzes the worldwide markets for Alzheimer's and Parkinson's Disease in Millions of US$. The Major product segments Analyzed are Anti-Alzheimer's Disease Drugs (Cholinesterase Inhibitors, & NMDARA), and Anti-Parkinson's... |
Pipeline and Commercial Insight: Osteoporosis
Novel agents to battle for payer acceptance
Introduction
Osteoporosis continues to be an attractive therapy area for large pharmaceutical companies due to its high prevalence rate and unmet need. Globally, sales for osteoporosis drugs grew 7.0% year-on-year from... |
Oncology Pipeline Database: 1-Year Subscription
Subscription to La Merie's proprietary Oncology Pipeline Database provides online access to more than 3,000 project entries in oncology. Each project is specified for its Target or Mechanism of Action,... |
Flat-Rate Subscription to La Merie Reports with 24/7 Online Access
Subscription to this product provides online access during one year to all reports published by La Merie and available in the online store during the subscription. Among La Merie reports... |
TGF-R Agonists and Antagonists
Competitor Analysis
The present Competitive Intelligence Report about TGF-R agonists and antagonists provides a competitor evaluation in the field of transforming growth factor receptor (TGF-R) or TGF targeting molecules for tissue healing... |
Sphingosine-1-Phosphate (S1P)
Competitor Analysis
Product description
The present Competitive Intelligence Report about Sphingosine-1-Phosphate (S1P) provides a competitor evaluation in the field of molecules interacting with the sphingosine-1-phosphate pathway as of November 2010. Among these molecules... |
Competitor Analysis: Adenosine Receptor Agonists & Antagonists
The present Competitive Intelligence Report about Adenosine Receptor Agonists & Antagonists provides a competitor evaluation in the field of novel molecules being developed for treatment of a variety of diseases... |
Targeted Therapy of Obesity
Competitor Analysis
The present Competitive Intelligence Report about Targeted Therapy of Obesity provides a competitor evaluation in the field of novel molecules being developed for treatment of obesity as of March 2011.... |
Hypertension: Competing Treatments and Market Entry Considerations
Today, approximately 1 billion people worldwide have high
blood pressure, a figure expected to increase to 1.5 billion by 2025, affecting
1 in 3 adults over the age of 20 (Lancet. 2005;365:217-223).... |
Competitor Analysis VEGF and VEGF-R Agonists and Antagonists
The present Competitive Intelligence Report about VEGF and VEGF-R agonists and antagonists provides a competitor evaluation in the field of VEGF and its receptor targeting molecules for treatment of cancer,... |
Autacoids and Related Drugs
Technologies and Global Markets
This Report
An Overview of Autacoids, Including Such Types as Histamines and Antihistamines, Prostaglandins, Angiotensin, Leukotriens, Prostanoids, Lipids, Nitrogen Bases, Reactive Oxygen Species, Nitric Oxide, and Small Oligopeptides
Analysis of Market Trends... |
Stakeholder Insight: Osteoporosis
Generic alendronate further establishes oral bisphosphonates as gold standard
Almost 100 million post-menopausal women suffer from osteopenia and osteoporosis in the seven major markets. Those diagnosed are often identified through screening for low bone mineral density or after presenting... |
GLP-1 Receptor Agonists
Competitor Analysis
Product description
The Competitive Intelligence Report Glucagon-Like Peptide-1 (GLP-1) Analogs as of November 2008 provides a competitor analysis in the development pipeline of novel GLP-1 Analogs and GLP-1 receptor agonists for... |
FSH, hCG and LH - Therapeutic Proteins for Assisted Reproductive Technology (ART)
Competitor Analysis
The Competitive Intelligence Report FSH, hCG and LH: Therapeutic Proteins for Assisted Reproductive Technology (ART) as of January 2011 provides a competitor analysis in the development pipeline of novel recombinant,... |
Diabetes Drug Pipeline
Competitor Analysis
Product description
The Competitive Intelligence Report Diabetes Drug Pipeline as of November 2008 provides a competitor analysis in the development pipeline of novel antidiabetic treatment modalities for type 1 and 2... |
